William M. Sullivan is Director at Privia Health Group, Inc. (PRVA). They have made 18 open-market trades across 1 company since 2021, most recently 2024-05-22.
CIK 0001859839
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 18 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PRVA | 33,916 | $764K |
Shares reported on the most recent Form 4, priced at the 2024-05-23 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PRVA | SELL | 2024-03-08 | 2024-03-12 | $23.03 | $337K | -9.0% | -14.9% | -21.4% |
| PRVA | SELL · 10b5-1 | 2024-01-24 | 2024-01-26 | $23.07 | $736K | -11.8% | -10.9% | -19.9% |
| PRVA | SELL · 10b5-1 | 2023-12-28 | 2023-12-29 | $23.97 | $288K | -4.4% | -5.5% | -14.1% |
| PRVA | SELL · 10b5-1 | 2023-12-13 | 2023-12-15 | $23.54 | $565K | +6.0% | -5.2% | -9.6% |
| PRVA | SELL · 10b5-1 | 2023-09-15 | 2023-09-19 | $25.03 | $909K | +1.1% | +1.3% | +0.4% |
| PRVA | SELL · 10b5-1 | 2023-09-01 | 2023-09-06 | $26.46 | $961K | -7.8% | -8.9% | -18.3% |
| PRVA | SELL · 10b5-1 | 2023-08-18 | 2023-08-22 | $25.06 | $910K | +5.8% | -11.6% | -7.9% |
| PRVA | SELL · 10b5-1 | 2023-08-04 | 2023-08-08 | $27.10 | $984K | -5.1% | -2.2% | -14.8% |
| PRVA | SELL · 10b5-1 | 2023-07-21 | 2023-07-25 | $26.82 | $974K | +2.2% | -7.8% | -16.6% |
| PRVA | SELL · 10b5-1 | 2023-07-07 | 2023-07-11 | $25.00 | $893K | +6.9% | +7.1% | -8.4% |
| PRVA | SELL · 10b5-1 | 2023-06-27 | 2023-06-29 | $25.08 | $283K | -8.2% | +4.5% | -17.2% |
| PRVA | SELL · 10b5-1 | 2023-06-23 | 2023-06-27 | $24.56 | $605K | -2.0% | +0.9% | -15.8% |
| PRVA | SELL · 10b5-1 | 2023-06-09 | 2023-06-13 | $28.35 | $1.0M | -13.3% | -12.1% | -10.4% |
| PRVA | SELL · 10b5-1 | 2023-06-07 | 2023-06-09 | $25.04 | $25K | -11.6% | -10.1% | -8.4% |
| PRVA | SELL · 10b5-1 | 2023-05-31 | 2023-06-02 | $25.01 | $253K | +12.2% | +3.1% | +5.8% |
| PRVA | SELL · 10b5-1 | 2023-05-26 | 2023-05-31 | $24.44 | $592K | +14.3% | +5.4% | +3.6% |
| PRVA | SELL · 10b5-1 | 2023-05-12 | 2023-05-16 | $26.54 | $964K | -4.0% | +6.8% | +6.2% |
| PRVA | SELL · 10b5-1 | 2023-05-08 | 2023-05-10 | $30.02 | $432K | -4.6% | +2.5% | -3.2% |
| PRVA | SELL · 10b5-1 | 2023-04-28 | 2023-05-04 | $27.36 | $993K | -7.7% | -13.2% | -2.7% |
| PRVA | SELL · 10b5-1 | 2023-04-14 | 2023-04-18 | $25.14 | $913K | +7.3% | -1.9% | +4.3% |
| PRVA | SELL · 10b5-1 | 2023-03-17 | 2023-03-21 | $27.07 | $983K | +2.5% | -5.0% | -5.3% |
| PRVA | SELL | 2023-03-03 | 2023-03-07 | $28.57 | $1.0M | -4.8% | -3.1% | -15.6% |
| PRVA | SELL | 2023-02-17 | 2023-02-22 | $28.00 | $508K | +1.8% | -0.3% | -8.3% |
| PRVA | SELL | 2023-02-03 | 2023-02-07 | $26.57 | $965K | +8.7% | +7.3% | +15.8% |
| PRVA | SELL | 2023-01-20 | 2023-01-24 | $25.36 | $921K | +5.8% | +13.0% | +7.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.